IGC Pharma Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About IGC Pharma Inc
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer’s disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer’s disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer’s cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer’s disease, such as plaques or tangles.
/ 
Frequently asked questions
To buy IGC Pharma Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for IGC Pharma Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for IGC Pharma Inc is IGC:xase. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
IGC Pharma Inc has its primary listing on NYSE American. You can trade IGC Pharma Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, IGC Pharma Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include IGC Pharma Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like IGC Pharma Inc.